Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Bacteriophage Therapy Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Bacteriophage Therapy Revenue
  • 1.4 Covid-19 Implications on Market by Route of Administration
    • 1.4.1 Global Bacteriophage Therapy Market Size Growth Rate by Route of Administration: 2020 VS 2026
    • 1.4.2 Oral
    • 1.4.3 Topical
    • 1.4.4 Parenteral
  • 1.5 Market by Application
    • 1.5.1 Global Bacteriophage Therapy Market Share by Application: 2020 VS 2026
    • 1.5.2 Organ Transplantation
    • 1.5.3 Bacterial Infections
    • 1.5.4 Alcoholic Hepatitis
    • 1.5.5 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Bacteriophage Therapy Industry Impact
    • 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.6.2 Covid-19 Impact: Commodity Prices Indices
    • 1.6.3 Covid-19 Impact: Global Major Government Policy
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends

  • 2.1 Covid-19 Implications on Global Bacteriophage Therapy Market Perspective (2015-2026)
  • 2.2 Covid-19 Implications on Global Bacteriophage Therapy Growth Trends by Regions
    • 2.2.1 Bacteriophage Therapy Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Bacteriophage Therapy Historic Market Share by Regions (2015-2020)
    • 2.2.3 Bacteriophage Therapy Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Bacteriophage Therapy Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Bacteriophage Therapy Players (Opinion Leaders)

3 Covid-19 Implications on Competition Landscape by Key Players

  • 3.1 Global Top Bacteriophage Therapy Players by Market Size
    • 3.1.1 Global Top Bacteriophage Therapy Players by Revenue (2015-2020)
    • 3.1.2 Global Bacteriophage Therapy Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Bacteriophage Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Bacteriophage Therapy Market Concentration Ratio
    • 3.2.1 Global Bacteriophage Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Bacteriophage Therapy Revenue in 2019
  • 3.3 Bacteriophage Therapy Key Players Head office and Area Served
  • 3.4 Key Players Bacteriophage Therapy Product Solution and Service
  • 3.5 Date of Enter into Bacteriophage Therapy Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Implications on Market Size by Route of Administration (2015-2026)

  • 4.1 Global Bacteriophage Therapy Historic Market Size by Route of Administration (2015-2020)
  • 4.2 Global Bacteriophage Therapy Forecasted Market Size by Route of Administration (2021-2026)

5 Covid-19 Implications on Market Size by Application (2015-2026)

  • 5.1 Global Bacteriophage Therapy Market Size by Application (2015-2020)
  • 5.2 Global Bacteriophage Therapy Forecasted Market Size by Application (2021-2026)

6 North America Impact of COVID-19

  • 6.1 North America Bacteriophage Therapy Market Size (2015-2020)
  • 6.2 Bacteriophage Therapy Key Players in North America (2019-2020)
  • 6.3 North America Bacteriophage Therapy Market Size by Route of Administration (2015-2020)
  • 6.4 North America Bacteriophage Therapy Market Size by Application (2015-2020)

7 Europe Impact of COVID-19

  • 7.1 Europe Bacteriophage Therapy Market Size (2015-2020)
  • 7.2 Bacteriophage Therapy Key Players in Europe (2019-2020)
  • 7.3 Europe Bacteriophage Therapy Market Size by Route of Administration (2015-2020)
  • 7.4 Europe Bacteriophage Therapy Market Size by Application (2015-2020)

8 China Impact of COVID-19

  • 8.1 China Bacteriophage Therapy Market Size (2015-2020)
  • 8.2 Bacteriophage Therapy Key Players in China (2019-2020)
  • 8.3 China Bacteriophage Therapy Market Size by Route of Administration (2015-2020)
  • 8.4 China Bacteriophage Therapy Market Size by Application (2015-2020)

9 Japan Impact of COVID-19

  • 9.1 Japan Bacteriophage Therapy Market Size (2015-2020)
  • 9.2 Bacteriophage Therapy Key Players in Japan (2019-2020)
  • 9.3 Japan Bacteriophage Therapy Market Size by Route of Administration (2015-2020)
  • 9.4 Japan Bacteriophage Therapy Market Size by Application (2015-2020)

10 Southeast Asia Impact of COVID-19

  • 10.1 Southeast Asia Bacteriophage Therapy Market Size (2015-2020)
  • 10.2 Bacteriophage Therapy Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Bacteriophage Therapy Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Bacteriophage Therapy Market Size by Application (2015-2020)

11 India Impact of COVID-19

  • 11.1 India Bacteriophage Therapy Market Size (2015-2020)
  • 11.2 Bacteriophage Therapy Key Players in India (2019-2020)
  • 11.3 India Bacteriophage Therapy Market Size by Type (2015-2020)
  • 11.4 India Bacteriophage Therapy Market Size by Application (2015-2020)

12 Central & South America Impact of COVID-19

  • 12.1 Central & South America Bacteriophage Therapy Market Size (2015-2020)
  • 12.2 Bacteriophage Therapy Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Bacteriophage Therapy Market Size by Type (2015-2020)
  • 12.4 Central & South America Bacteriophage Therapy Market Size by Application (2015-2020)

13Key Players Profiles

  • 13.1 Armata Pharmaceuticals, Inc.
    • 13.1.1 Armata Pharmaceuticals, Inc. Company Details
    • 13.1.2 Armata Pharmaceuticals, Inc. Business Overview and Its Total Revenue
    • 13.1.3 Armata Pharmaceuticals, Inc. Bacteriophage Therapy Introduction
    • 13.1.4 Armata Pharmaceuticals, Inc. Revenue in Bacteriophage Therapy Business (2015-2020))
    • 13.1.5 Armata Pharmaceuticals, Inc. Recent Development and Reaction to COVID-19
  • 13.2 Eliava Biopreparations Ltd.
    • 13.2.1 Eliava Biopreparations Ltd. Company Details
    • 13.2.2 Eliava Biopreparations Ltd. Business Overview and Its Total Revenue
    • 13.2.3 Eliava Biopreparations Ltd. Bacteriophage Therapy Introduction
    • 13.2.4 Eliava Biopreparations Ltd. Revenue in Bacteriophage Therapy Business (2015-2020)
    • 13.2.5 Eliava Biopreparations Ltd. Recent Development and Reaction to COVID-19
  • 13.3 Pherecydes Pharma
    • 13.3.1 Pherecydes Pharma Company Details
    • 13.3.2 Pherecydes Pharma Business Overview and Its Total Revenue
    • 13.3.3 Pherecydes Pharma Bacteriophage Therapy Introduction
    • 13.3.4 Pherecydes Pharma Revenue in Bacteriophage Therapy Business (2015-2020)
    • 13.3.5 Pherecydes Pharma Recent Development and Reaction to COVID-19
  • 13.4 Intralytix, Inc.
    • 13.4.1 Intralytix, Inc. Company Details
    • 13.4.2 Intralytix, Inc. Business Overview and Its Total Revenue
    • 13.4.3 Intralytix, Inc. Bacteriophage Therapy Introduction
    • 13.4.4 Intralytix, Inc. Revenue in Bacteriophage Therapy Business (2015-2020)
    • 13.4.5 Intralytix, Inc. Recent Development and Reaction to COVID-19
  • 13.5 Phagelux Inc.
    • 13.5.1 Phagelux Inc. Company Details
    • 13.5.2 Phagelux Inc. Business Overview and Its Total Revenue
    • 13.5.3 Phagelux Inc. Bacteriophage Therapy Introduction
    • 13.5.4 Phagelux Inc. Revenue in Bacteriophage Therapy Business (2015-2020)
    • 13.5.5 Phagelux Inc. Recent Development and Reaction to COVID-19
  • 13.6 Nextbiotics
    • 13.6.1 Nextbiotics Company Details
    • 13.6.2 Nextbiotics Business Overview and Its Total Revenue
    • 13.6.3 Nextbiotics Bacteriophage Therapy Introduction
    • 13.6.4 Nextbiotics Revenue in Bacteriophage Therapy Business (2015-2020)
    • 13.6.5 Nextbiotics Recent Development and Reaction to COVID-19
  • 13.7 InnoPhage, Ltd
    • 13.7.1 InnoPhage, Ltd Company Details
    • 13.7.2 InnoPhage, Ltd Business Overview and Its Total Revenue
    • 13.7.3 InnoPhage, Ltd Bacteriophage Therapy Introduction
    • 13.7.4 InnoPhage, Ltd Revenue in Bacteriophage Therapy Business (2015-2020)
    • 13.7.5 InnoPhage, Ltd Recent Development and Reaction to COVID-19
  • 13.8 Locus Biosciences, Inc.
    • 13.8.1 Locus Biosciences, Inc. Company Details
    • 13.8.2 Locus Biosciences, Inc. Business Overview and Its Total Revenue
    • 13.8.3 Locus Biosciences, Inc. Bacteriophage Therapy Introduction
    • 13.8.4 Locus Biosciences, Inc. Revenue in Bacteriophage Therapy Business (2015-2020)
    • 13.8.5 Locus Biosciences, Inc. Recent Development and Reaction to COVID-19
  • 13.9 TechnoPhage
    • 13.9.1 TechnoPhage Company Details
    • 13.9.2 TechnoPhage Business Overview and Its Total Revenue
    • 13.9.3 TechnoPhage Bacteriophage Therapy Introduction
    • 13.9.4 TechnoPhage Revenue in Bacteriophage Therapy Business (2015-2020)
    • 13.9.5 TechnoPhage Recent Development and Reaction to COVID-19
  • 13.10 Eligo Bioscience SA
    • 13.10.1 Eligo Bioscience SA Company Details
    • 13.10.2 Eligo Bioscience SA Business Overview and Its Total Revenue
    • 13.10.3 Eligo Bioscience SA Bacteriophage Therapy Introduction
    • 13.10.4 Eligo Bioscience SA Revenue in Bacteriophage Therapy Business (2015-2020)
    • 13.10.5 Eligo Bioscience SA Recent Development and Reaction to COVID-19
  • 13.11 Phagomed Biopharma GmbH.
    • 10.11.1 Phagomed Biopharma GmbH. Company Details
    • 10.11.2 Phagomed Biopharma GmbH. Business Overview and Its Total Revenue
    • 10.11.3 Phagomed Biopharma GmbH. Bacteriophage Therapy Introduction
    • 10.11.4 Phagomed Biopharma GmbH. Revenue in Bacteriophage Therapy Business (2015-2020)
    • 10.11.5 Phagomed Biopharma GmbH. Recent Development and Reaction to COVID-19
  • 13.12 PhagePro, Inc.
    • 10.12.1 PhagePro, Inc. Company Details
    • 10.12.2 PhagePro, Inc. Business Overview and Its Total Revenue
    • 10.12.3 PhagePro, Inc. Bacteriophage Therapy Introduction
    • 10.12.4 PhagePro, Inc. Revenue in Bacteriophage Therapy Business (2015-2020)
    • 10.12.5 PhagePro, Inc. Recent Development and Reaction to COVID-19
  • 13.13 Adaptive Phage Therapeutics, Inc.
    • 10.13.1 Adaptive Phage Therapeutics, Inc. Company Details
    • 10.13.2 Adaptive Phage Therapeutics, Inc. Business Overview and Its Total Revenue
    • 10.13.3 Adaptive Phage Therapeutics, Inc. Bacteriophage Therapy Introduction
    • 10.13.4 Adaptive Phage Therapeutics, Inc. Revenue in Bacteriophage Therapy Business (2015-2020)
    • 10.13.5 Adaptive Phage Therapeutics, Inc. Recent Development and Reaction to COVID-19
  • 13.14 EnBiotix, Inc.
    • 10.14.1 EnBiotix, Inc. Company Details
    • 10.14.2 EnBiotix, Inc. Business Overview and Its Total Revenue
    • 10.14.3 EnBiotix, Inc. Bacteriophage Therapy Introduction
    • 10.14.4 EnBiotix, Inc. Revenue in Bacteriophage Therapy Business (2015-2020)
    • 10.14.5 EnBiotix, Inc. Recent Development and Reaction to COVID-19
  • 13.15 Intodeworld, Inc.
    • 10.15.1 Intodeworld, Inc. Company Details
    • 10.15.2 Intodeworld, Inc. Business Overview and Its Total Revenue
    • 10.15.3 Intodeworld, Inc. Bacteriophage Therapy Introduction
    • 10.15.4 Intodeworld, Inc. Revenue in Bacteriophage Therapy Business (2015-2020)
    • 10.15.5 Intodeworld, Inc. Recent Development and Reaction to COVID-19
  • 13.16 BiomX Ltd.
    • 10.16.1 BiomX Ltd. Company Details
    • 10.16.2 BiomX Ltd. Business Overview and Its Total Revenue
    • 10.16.3 BiomX Ltd. Bacteriophage Therapy Introduction
    • 10.16.4 BiomX Ltd. Revenue in Bacteriophage Therapy Business (2015-2020)
    • 10.16.5 BiomX Ltd. Recent Development and Reaction to COVID-19
  • 13.17 Phi Therapeutics
    • 10.17.1 Phi Therapeutics Company Details
    • 10.17.2 Phi Therapeutics Business Overview and Its Total Revenue
    • 10.17.3 Phi Therapeutics Bacteriophage Therapy Introduction
    • 10.17.4 Phi Therapeutics Revenue in Bacteriophage Therapy Business (2015-2020)
    • 10.17.5 Phi Therapeutics Recent Development and Reaction to COVID-19
  • 13.18 Fixed-phage Ltd.
    • 10.18.1 Fixed-phage Ltd. Company Details
    • 10.18.2 Fixed-phage Ltd. Business Overview and Its Total Revenue
    • 10.18.3 Fixed-phage Ltd. Bacteriophage Therapy Introduction
    • 10.18.4 Fixed-phage Ltd. Revenue in Bacteriophage Therapy Business (2015-2020)
    • 10.18.5 Fixed-phage Ltd. Recent Development and Reaction to COVID-19
  • 13.19 Micreos BV
    • 10.19.1 Micreos BV Company Details
    • 10.19.2 Micreos BV Business Overview and Its Total Revenue
    • 10.19.3 Micreos BV Bacteriophage Therapy Introduction
    • 10.19.4 Micreos BV Revenue in Bacteriophage Therapy Business (2015-2020)
    • 10.19.5 Micreos BV Recent Development and Reaction to COVID-19
  • 13.20 ContraFect Corporation
    • 10.20.1 ContraFect Corporation Company Details
    • 10.20.2 ContraFect Corporation Business Overview and Its Total Revenue
    • 10.20.3 ContraFect Corporation Bacteriophage Therapy Introduction
    • 10.20.4 ContraFect Corporation Revenue in Bacteriophage Therapy Business (2015-2020)
    • 10.20.5 ContraFect Corporation Recent Development and Reaction to COVID-19

14Analyst's Viewpoints/Conclusions

    15Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Bacteriophage Therapy market is segmented by Route of Administration, and by Application. Players, stakeholders, and other participants in the global Bacteriophage Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Route of Administration and by Application in terms of revenue and forecast for the period 2015-2026.
    Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Bacteriophage Therapy market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
    This report also analyzes the impact of Coronavirus COVID-19 on the Bacteriophage Therapy industry.

    The key players covered in this study
    Armata Pharmaceuticals, Inc.
    Eliava Biopreparations Ltd.
    Pherecydes Pharma
    Intralytix, Inc.
    Phagelux Inc.
    Nextbiotics
    InnoPhage, Ltd
    Locus Biosciences, Inc.
    TechnoPhage
    Eligo Bioscience SA
    Phagomed Biopharma GmbH.
    PhagePro, Inc.
    Adaptive Phage Therapeutics, Inc.
    EnBiotix, Inc.
    Intodeworld, Inc.
    BiomX Ltd.
    Phi Therapeutics
    Fixed-phage Ltd.
    Micreos BV
    ContraFect Corporation

    Market segment by Route of Administration, the product can be split into
    Oral
    Topical
    Parenteral
    Market segment by Application, split into
    Organ Transplantation
    Bacterial Infections
    Alcoholic Hepatitis
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Bacteriophage Therapy status, future forecast, growth opportunity, key market and key players.
    To present the Bacteriophage Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by route of administration, market and key regions.

    In this study, the years considered to estimate the market size of Bacteriophage Therapy are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, route of administration and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
    Buy now